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Abstract: BACKGROUND: What constitutes a hemodynamically relevant patent ductus arteriosus
(hrPDA) in preterm infants is unclear. Different clinical and echocardiographic parameters are used,
but a gold standard definition is lacking. Our objective was to evaluate associations between regional
cerebral tissue oxygen saturation (rcStO2), fraction of tissue oxygen extraction (rcFtO2E) measured
by frequency domain near-infrared spectroscopy (fd-NIRS) and their correlation to echocardiographic,
Doppler-ultrasound, and clinical parameters in preterm infants with and without a hrPDA. METHODS:
In this prospective observational study, 22 infants < 1500 g (mean [± SD]: gestational age 28.6 [±1.8]
weeks, birth weight 1076 [±284] g, median (interquartile range) postnatal age at measurement 7.6 (4.6-
12.9) d) with a clinical suspicion of hrPDA were analysed. Twelve infants had left-to-right shunt through
PDA, and in 6 of these the PDA was classified as hrPDA based on pre-defined clinical and echocar-
diographic criteria. fd-NIRS, echocardiographic and Doppler-ultrasound examinations were performed.
After identification of blood hemoglobin (Hb) as confounding factor, rcStO2 and rcFtO2E were corrected
for this effect. RESULTS: Overall mean ± standard deviation (normalised to a median Hb of 13.8 mg/dl)
was 57 ±5% for rcStO2 and 0.39 ±0.05 for rcFtO2E. Comparing no-hrPDA with hrPDA infants, there
were no significant differences in mean rcStO2 (58 ±5% vs. 54 ±5%; p = .102), but in mean rcFtO2E
(0.38 ±0.05 vs. 0.43 ±0.05; p = .038). Echocardiographic parameter and Doppler indices did not corre-
late with cerebral oxygenation. CONCLUSION: Oxygen transport capacity of the blood may confound
NIRS data interpretation. Cerebral oxygenation determined by fd-NIRS provided additional information
for PDA treatment decisions not offered by routine investigations. Whether indicating PDA therapy
based on echocardiography complemented by data on cerebral oxygenation results in better outcomes
should be investigated in future studies.
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Abstract
Background: What constitutes a hemodynamically relevant patent ductus arteriosus (hrPDA) in preterm infants is
unclear. Different clinical and echocardiographic parameters are used, but a gold standard definition is lacking.
Our objective was to evaluate associations between regional cerebral tissue oxygen saturation (rcStO2), fraction of tissue
oxygen extraction (rcFtO2E) measured by frequency domain near-infrared spectroscopy (fd-NIRS) and their correlation to
echocardiographic, Doppler-ultrasound, and clinical parameters in preterm infants with and without a hrPDA.
Methods: In this prospective observational study, 22 infants < 1500 g (mean [± SD]: gestational age 28.6 [±1.8] weeks,
birth weight 1076 [±284] g, median (interquartile range) postnatal age at measurement 7.6 (4.6–12.9) d) with a clinical
suspicion of hrPDA were analysed.
Twelve infants had left-to-right shunt through PDA, and in 6 of these the PDA was classified as hrPDA based on
pre-defined clinical and echocardiographic criteria. fd-NIRS, echocardiographic and Doppler-ultrasound examinations
were performed. After identification of blood hemoglobin (Hb) as confounding factor, rcStO2 and rcFtO2E were
corrected for this effect.
Results: Overall mean ± standard deviation (normalised to a median Hb of 13.8 mg/dl) was 57 ±5% for rcStO2 and 0.39
±0.05 for rcFtO2E. Comparing no-hrPDA with hrPDA infants, there were no significant differences in mean rcStO2 (58
±5% vs. 54 ±5%; p = .102), but in mean rcFtO2E (0.38 ±0.05 vs. 0.43 ±0.05; p = .038). Echocardiographic parameter and
Doppler indices did not correlate with cerebral oxygenation.
Conclusion: Oxygen transport capacity of the blood may confound NIRS data interpretation. Cerebral oxygenation
determined by fd-NIRS provided additional information for PDA treatment decisions not offered by routine investigations.
Whether indicating PDA therapy based on echocardiography complemented by data on cerebral oxygenation results in
better outcomes should be investigated in future studies.
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Background
Screening for, and therapy of, patent ductus arteriosus
(PDA) in preterm infants is associated with decreased
mortality and morbidity [1]. However, there is little evi-
dence as to which parameters define a PDA that requires
treatment, i.e. is hemodynamically relevant (hrPDA).
Zonnenberg and de Waal summarized which echocar-
diographic and Doppler-ultrasound measurements, be-
sides clinical parameters, have been used to evaluate the
magnitude and clinical relevance of left-to-right shunt-
ing through a PDA [2]. Scoring Systems like the one
suggested by McNamara and Sehgal include clinical and
echocardiographic criteria to define hrPDA [3]. The
echocardiographic part of this staging is useful to predict
neonatal morbidity and may serve as a guide to clinical
decision-making [4]. Resistive index (RI) in the anterior
cerebral artery (ACA) was shown to be significantly
higher in infants with hrPDA [5].
With frequency domain near-infrared spectroscopy
(fd-NIRS) regional cerebral tissue oxygen saturation
(rcStO2) and (together with pulse oximetry data) tissue
oxygen extraction (rcFtO2E) may be monitored noninva-
sively. In a recent observational study using continuous
wave (cw) NIRS, significant differences in cerebral oxy-
genation over time were observed in infants born below
32 weeks gestation within their first 6 postnatal days [6].
Such an effect, however, was not identified in other
recent studies using this technique [7, 8].
To inform future studies and clinical guidelines on
PDA treatment, this study aimed to evaluate the abso-
lute cerebral oxygenation of preterm infants besides
echocardiographic and Doppler-ultrasound parameters,
which are frequently determined to assess the need for
PDA treatment.
Methods
This prospective observational cohort study was ap-
proved by the institutional research ethics committee
and written informed parental consent obtained. Inclu-
sion criteria were gestational age (GA) <37 weeks, birth
weight (bw) ≤1500 g and clinical suspicion of hrPDA
such as cardiac murmur, bounding pulses, ventilator
dependency, metabolic acidosis and increased oxygen
requirements. Syndromal anomalies and congenital heart
defects except persisting foramen ovale or atrial septal
defect were exclusion criteria. Recruitment took place
from June 2012 to May 2013 and September 2015 to
March 2016 at the tertiary level neonatal intensive care unit
of the university children’s hospital, Tuebingen, Germany.
Fd-NIRS-measurements
In infants with clinical indication for echocardiography
based on a clinical suspicion of PDA, fd-NIRS was mea-
sured at the time of echocardiography. The reflectance
mode multi-distance fd-NIRS device OxiplexTS (ISS Inc.
Champaign, Illinois, U.S.A.) measures mean intensity
(DC), modulation amplitude (AC) and phase shift (PH)
at 4 distances and 2 wavelengths and determines abso-
lute values of cerebral oxy-, deoxy-, total hemoglobin
concentration and rcStO2. The optode was placed, as
previously described [9], in a temporo-parietal position
half-way between tragus and sagittal suture. The optode
was held by the examiner for 5 consecutive measure-
ments of 1 min each at either side of the head; it was
repositioned between measurement runs [9]. The tissue
water content was assumed to be 90% [10]. To exclude
effects of tissue inhomogeneity, a quality criteria algo-
rithm was used with r2 >0.8 in the linear regression ana-
lyses for AC, DC and PH over the four emitter-optode
distances as surrogate according to Arri et al. [11]. We
decided to use this cut-off because higher cut-offs for r2
were unable to increase precision significantly but led to
loss of information. To overcome inaccuracy of single
measurements [12] we used the mean of up to 10 mea-
surements over 1 min each. Recording frequency was
1 Hz. Intra-observer repeatability was evaluated post-hoc
by within-subject SD (SDW) estimated as square root of
the residual mean square by oneway-ANOVA with subject
as factor according to Hyttel-Sorensen et al. [13]. The
SDW was ±7% for rcStO2 and ±0.08 for rcFtO2E.
Echocardiographic and Doppler-ultrasound
measurements
The Parameters assessed were LA/Ao-ratio [14], diameter
of the PDA at its narrowest part [15], the left-ventricular-
preejection-period-to-ejection-time-ratio, calculated by
including 3–4 cardiac cycles (LVPEP/LVET) [16], and the
ratio of the velocity time integrals in the large vessels aorta
and pulmonary artery (VTI_Ao/VTI_PA). The VTI_Ao
was recorded from an apical-5-chamber-view, the VTI_PA
in a parasternal short axis. We assumed that, in the
absence of congenital heart defects, this ratio correlates
with the ductal left-to-right shunt. After visualisation of
the whole course of the PDA, its diameter was measured
at its narrowest part (identified via colour-Doppler in the
high left-sided parasternal “ductal” view and the supraster-
nal view) and measured in B-Mode to avoid the influence
of gain-settings on the PDA-width. RI in celiac artery
(CA) [17] and ACA [18] were measured as well. Based on
our previous analyses on repeatability of echocardiographic
parameters [19], mean values of repeated measurements
were assessed whenever possible (i.e., in 18/22 infants, in 4
patients only single measurements were available).
All measurements were performed with a Toshiba
“Aplio” using a 6.5 MHz phased array transducer (Toshiba
Medical Systems, Otawara-shi, Tochigi-ken, Japan) or a
Zonare ZS3 using C10–3 curved-phased array transducer
(Zonare Medical Systems, Inc., Mountain View, CA,
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U.S.A.). For calculation of velocity time integrals, the
former device enables automatic detection while the latter
device requires manual circumscription of the Doppler
wave form.
Cardiorespiratory monitoring and laboratory
investigations
During measurements, heart rate (HR) and peripheral
arterial oxygen saturation (SpO2) were monitored in all pa-
tients via pulse oximetry (Radical 7; Masimo Corporation,
Irvine, CA, U.S.A.) and the SpO2 was targeted at 90–95% if
on supplemental oxygen and at > 89% if no supplemental
oxygen was used. Averaging and recording intervals were
2 s each. As for fd-NIRS measurements, we calculated
means for each 1-min measurement of these parameters.
Blood hemoglobin concentration (Hb in g/dL) from clinic-
ally indicated whole blood counts was extracted from
patients’ charts if determined within ±12 h of NIRS-
measurements or by linear interpolation of the two adja-
cent Hb concentrations.
Definition of hrPDA
According to the clinical standard in use in the unit,
hrPDA was defined if a left-to-right shunt through a
PDA was confirmed by echocardiography and at least 3
of the following 6 criteria were met:
1. LA/Ao-ratio >1.5
2. PDA diameter ≥1.5 mm/kg bodyweight
3. Need of respiratory support (mechanical Ventilation
or continuous positive airway pressure with
supplemental oxygen)
4. Reverse or zero end diastolic flow in ACA
(=RI_ACA ≥ 1)
5. Reverse or zero end diastolic flow in CA (=RI_
CA ≥ 1)
6. LVPEP/LVET <0.32
Infants with left-to-right shunt through a PDA meeting
less than 3 of the above listed criteria were classified as
hiPDA (hemodynamically irrelevant) and allocated, together
with infants without a PDA, to the no-hrPDA group.
Statistical analyses
RcStO2 was extracted and rcFtO2E calculated from rcStO2
and SpO2 data according to Naulaers et al. [20]. Results
were screened for potential confounding factors (GA, BW,
age at measurement (AAM), gender, Hb, small for gesta-
tional age (SGA)) by Spearman-Rho/Pearson correlation
coefficient and Fisher’s exact test, as appropriate. If a
statistically significant influence was identified on univari-
ate analysis, rcStO2 and rcFtO2E were normalized for the
median of this confounding factor.
Patients were stratified into 2 groups: no-hrPDA and
hrPDA according to echocardiographic and clinical param-
eters (see definition of hrPDA). Demographic, neonatal and
echocardiographic parameters were tested for significant
group differences using t-, Mann-Whitney-U and Fisher’s
exact test, oneway-ANOVA or Welch-Test, as appropriate.
RcStO2 and rcFtO2E were tested for statistically signifi-
cant differences with oneway-ANOVA after confirmation
of normal distribution (Shapiro-Wilk) and homogeneity of
variances (Levene-statistics).
A p-value below.05 was set to indicate statistical sig-
nificance. Data are presented as median and interquartile
range (IQR) or mean and ± standard deviation (±SD) if
not noted otherwise. Where appropriate, 95% confidence
intervals (CI) were added. SPSS-Statistics (Version
24.0.0.0, IBM Corporation, Armonk, NY, U.S.A.) was
used for statistical analyses.
Results
Demographic and neonatal parameters
Twenty-four infants were included in the study. One
infant with a BW of 1550 g was included inadvertently
due to a body weight at the time of measurement of
1465 g (hiPDA). Two infants were excluded: one infant
of 23 weeks GA, BW 360 g, due to fulminant sepsis a
few hours after inclusion leading to its demise (hrPDA),
so that cerebral oxygenation and hemodynamics could
have been corrupted, the other (GA 26 weeks, BW
745 g) due to a ventricular septal defect found during
his study echocardiography (hiPDA). Demographic and
clinical data of the 22 preterm infants analysed in this
cohort are summarized in Table 1.
Three infants in the hrPDA group had indomethacin
within 24 h prior to measurements (0.1/0.2/0.4 mg/kg
BW/day, respectively). Overall, 5 patients needed ino-
tropes and 6 had medical therapy for PDA closure
according to the clinical standard in use in the unit. No
infant underwent surgical closure of PDA.
Echocardiographic und Doppler-ultrasound
measurements
A left-to-right shunt through PDA was identified by colour-
Doppler-ultrasound in 12/22 measurements. PDA-diameter
at the narrowest part could rarely be measured (n = 6) due
to difficulties visualizing the PDA in its complete course in
B-mode. PDA staging classified 6 PDAs as hrPDA and 6 as
hiPDA. All 6 parameters used to define hrPDA were rele-
vantly different between groups. Mean VTI_Ao/VTI_PA in
hrPDA vs. no-hrPDA was 1.43 ±0.56 (95% CI 0.84, 2.02) vs.
0.93 ±0.24 (95% CI 0.80,1.06), p = .085 (Table 2).
NIRS and confounding factors
The oxygen transport capacity of the blood represented
by Hb concentration was identified as a confounding
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factor on rcStO2 and rcFtO2E by Spearman-Rho
(p = .022 and .004, respectively). Pearson correlation
showed a significant influence as well (p = .023 and .003,
respectively), supporting a linear relationship. We thus
normalized rcStO2 and rcFtO2E for Hb using the linear
regression equation:
normalized rcStO2 ¼ 1; 1312 medianHb−patientHbð Þ
þmeasured rcStO2; r2 ¼ 0:2338
and
normalized rcFtO2E ¼ −0:0153 medianHb−patientHbð Þ
þmeasured rcFtO2E; r2 ¼ 0:3669
After normalization for a median Hb value of 13.8 mg/
dl, the overall mean rcStO2 was 57 ±5% (95% CI: 55%,
60%) and mean rcFtO2E 0.40 ± 0.05 (95% CI 0.37, 0.41),
respectively. Mean RcStO2 of hrPDA vs. no-hrPDA infants
was 54 ±5% (95% CI 49%, 59%) vs. 58 ±5% (95% CI 56%,
61%; p = .102). However, rcFtO2E mean was 0.43 ±0.05
(95% CI 0.38, 0.48) vs. 0.38 ±0.05 (95% CI 0.35, 0.40;
p = .038) (Table 3).
None of the echocardiographic or Doppler-ultrasound
parameters correlated significantly with Hb-normalized
rcStO2 or Hb-normalized rcFtO2E.
Discussion
Using fd-NIRS and normalization for Hb, we found a
significant difference in rcFtO2E, but not in rcStO2,
between infants with vs. without hrPDA in our cohort.
As neither Hb-normalized rcStO2 nor rcFtO2E corre-
lated with echocardiographic or Doppler-ultrasound
parameters, fd-NIRS parameters of cerebral oxygenation
may offer additional information and may help to better
inform treatment decisions.
In general, a good diagnostic parameter can easily and
quickly be determined, has high sensitivity and specifi-
city and is not incriminating to measure in preterm
infants. NIRS is a non-invasive technique, and lower
cerebral oxygenation within the first 2 postnatal weeks
has been associated with poorer neurodevelopmental
long term outcome of preterm infants [21]. Suboptimal
cerebral oxygenation due to a hrPDA may negatively
influence brain growth at term-equivalent age [22] and,
at least in animal models, rcStO2 values below 40% are
identified as a risk factor for an impaired neurodevelop-
ment [23].
Data on PDA-related changes in cerebral oxygenation
are still controversial, although an impact on cerebral
oxygenation has been identified in several studies. In a
recent prospective observational trial involving 380
infants of <32 weeks gestation studied during their first
6 days postnatal days, Dix et al. found significant differ-
ences in cerebral oxygenation over time [6]. In line with
these data, rcFtO2E showed a statistically significant
difference between hr- and non-hrPDA, whereas rcStO2






Gestational age (weeks) 28.5 (25.9–29.4) 28.8 (28.5–29.7) 0.33
Birth weight (g) 1110 (793–1128) 1090 (879–1346) 0.43
Small for gestational age 0 2
Male 2 11 0.18
Age at measurement (d) 4.7 (4.6–7.2) 8.1 (4.5–21.7) 0.26
Weight at measurement (g) 1118 (788–1162) 1233 (1001–1675) 0.23
Mechanical Ventilation 2 2
CPAP 4 9
Fraction of inspired Oxygen 0.23 0.21 0.80
Hb (g/dl) 15.0 (13.9–15.2) 12.6 (11.2–14.6) 0.08
SpO2 (%) 94 (93–96) 95 (92–95) 0.51
HR (1/min) 163 (158–175) 161 (154–168) 0.33
meanBP (mmHg) 37 (35–40) 46 (41–49) 0.01
Inotropes 0 0
Values are median (interquartile range) or n; CPAP: continuous positive airway
pressure, Hb: hemoglobin concentration, SpO2: pulse oximetry measured
arterial oxygen saturation, HR: heart rate, meanBP: mean blood pressure






Left-to-right shunt PDA 6 6
LA/Ao 1.6 (1.4–1.8) 1.3 (1.2–1.5) .15
PDA_diameter/kgBW 1.6 (1.4–2.1) 0.6 (.6–.6) ns
RI_ACA .86 (.83–.89) .77 (.75–.82) .01
RI_CA 1 (.86–1) .77 (.71–.82) .04
LVPEP/LVET .26 (.21–.28) .31 (.28–.33) .09
VTI_Ao/VTI_PA 1.5 (.97–1.9) .9 (.84–1.0) .08
Values are median (interquartile range) or n; separated in hemodynamically
relevant (hr) Patent ductus arteriosus (PDA) and no-hrPDA. Left atrium (LA),
Aortic root (Ao), diameter of PDA, measured at its most constricted point, per
kilogram of bodyweight (BW), Resistive indices (RI) in anterior cerebral artery
(ACA) and celiac artery (CA), Left ventricular (LV) pre-ejection period (PEP) and
ejection time (ET), Velocity time integral (VTI) and pulmonary artery (PA), bold:
The ratio of VTI_Ao to VTI_PA was the only parameter not used in the definition
of hrPDA, italic: PDA diameter/kgBW could rarely be measured (n = 6; 4 hrPDA
and 2 no-hrPDA), statistical test: oneway-ANOVA or Welch-test, as appropriate






rcStO2 (%) 54 (±5) 58 (±5) .102
rcFtO2E .43 (±.05) .38 (±.05) .038
Values are mean (±SD), test for significance: oneway-ANOVA, regional cerebral
(rc) tissue oxygen saturation (StO2) and fraction of tissue oxygen extraction
(FtO2E) normalized for median hemoglobin
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did not, but this latter observation may be due limited
power due to our small sample size. Another explan-
ation might be an effect of (small) changes in arterial
oxygen saturation during measurements, which are not
addressed by rcStO2. Chock et al. studied 47 infants with
GA below 29 weeks (21 echocardiographically stratified
as hrPDA) and found no significant relationship to
rcStO2 [7]. In line with this, others reported data on 20
hrPDA compared with 29 non-hrPDA preterm infants
(median GA 27.6 weeks, median BW 980 g) and found
no significant effect on rcStO2 or rcFtO2E [8]. Older
observational trials found a pronounced impact of
hrPDA on cerebral oxygenation in infants scheduled for
surgical closure [24–28]. In the present cohort, no
infants underwent surgical ligation due to a very restrict-
ive policy on surgical PDA closure in our unit.
Contrary to previous studies using cw-NIRS devices,
fd-NIRS provides absolute instead of trend values for
rcStO2 under the assumption of a homogenous semi-
infinite tissue. Another advantage of this technique is
the opportunity of extracting unprocessed optical raw
data, enabling the introduction of a quality pre-analytic
algorithm for using high quality data for analysis,
thereby improving repeatability. A disadvantage is that
this instrument is less practical for continuous bedside
trend monitoring due to the use of fragile glass fibre
cables as well as its non-disposable probe.
Overall mean values for rcStO2 were within the
(lower) normal range [29], taking into account that this
“normal range” was established for the first 72 h of life,
while our cohort consisted of older preterm infants.
Both, device and sensor, but also the clinical suspicion of
hrPDA and/or the higher postnatal age may have con-
tributed to these slightly lower values [30].
A variety of confounding factors impacting on cerebral
oxygenation as measured with NIRS are known. Growth
restriction, gender and gestational age have already been
identified [6, 31, 32]. We were unable to reproduce these
findings, possibly due to our low sample size. Only Hb
concentration was identified as a confounder so that
rcStO2 and rcFtO2E were normalized for median Hb
before further analysis. This should be addressed in
future investigations. The higher rcFtO2E observed with
hrPDA supports previous suggestions to maintain higher
Hb concentrations in infants with hrPDA as part of con-
servative management [25]. Whether this might have an
effect on long term outcome has not been studied yet.
We found no significant correlation between echocar-
diographic or Doppler-ultrasound parameters and cerebral
oxygenation. A large number of different echocardio-
graphic and Doppler-ultrasound parameters are used to
quantify left-to-right shunting through, and hemodynamic
relevance of, a PDA (summarised in [2]). This is reflected
in NIRS-studies on hrPDA and its effect on cerebral
oxygenation by relevant differences in hrPDA definition
[7, 8, 33]. This substantially complicates comparisons
between studies on hrPDA. The cut-offs used here reflect
local preferences and the number of parameters tested
was limited to reduce examination time and hence study-
driven burden on infants.
To our knowledge only Dix et al. identified a significant
relation between an echocardiographic parameter (ductal
diameter) and rcStO2 [6]. We were only rarely able to
measure PDA diameter due to our strict definition of
the most constricted point at the whole course of the
PDA in B-mode. In line with our results Dix et al. found
no relation between LA/Ao and cerebral oxygenation.
Before embarking on this study, we assumed that the
VTI_Ao/VTI_PA-ratio might be another easily determined
parameter suitable for quantifying ductal left-to-right shunt
under the assumption of a “normal” ratio of Ao to PA
valve-area. It is also important to have in mind that it could
be corrupted by inter-atrial shunting, which is commonly
observed in VLBW infants (and also in 20 of the infants
studied here). However, this limitation also applies to LA/
Ao ratio, the most commonly used parameter. VTI_Ao/
VTI_PA-ratio has a relatively low repeatability and could be
corrupted by ductal jet, although it is supposed to allow
discrimination between hrPDA and hiPDA [19].
Limitations of this study are its small sample size and that
extremely low gestational age infants, who are most likely
to develop hrPDA, were under-represented. We have been
reluctant to subject the more immature and hence more
vulnerable infants to the additional study-related burden.
By contrast, it is a strength of our study that fd-NIRS
was used, truly generating absolute values for rcStO2
and rcFtO2E and that a rigorous quality assessment of
the raw data preceded further analyses. Furthermore, we
identified that Hb was an important confounder of
cerebral oxygenation in this context and therefore
assessed Hb-normalized values of NIRS parameters.
Only 5 patients overall were ever treated for PDA – this
reflects the very restrictive approach to PDA treatment
present in our unit - others may be more proactive [6].
Conclusions
Oxygen transport capacity of the blood may be taken
into account for NIRS data interpretation. In our cohort
we found a statistically significant difference in absolute
cerebral oxygenation between clinically and echocardio-
graphically defined hrPDA compared to no-hrPDA in-
fants. Furthermore, our data suggest that parameters of
cerebral oxygenation might offer additional information
for the clinical decision whether or not to treat a PDA
in an individual infant. Whether indicating PDA therapy
based on echocardiography complemented by data on
cerebral oxygenation results in better outcomes should
be investigated in future studies.
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